Molecular hybridization of 4-azahexacyclo[5.4.1.02,6.03,10.05,9.08,11] dodecane-3-ol with sigma (σ) receptor ligands modulates off-target activity and subtype selectivity

被引:14
作者
Banister, Samuel D. [1 ]
Moussa, Iman A. [1 ]
Jorgensen, William T. [1 ]
Chua, Sook Wern [2 ]
Kassiou, Michael [1 ,2 ,3 ]
机构
[1] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia
[2] Brain & Mind Res Inst, Sydney, NSW 2050, Australia
[3] Univ Sydney, Discipline Med Radiat Sci, Sydney, NSW 2006, Australia
关键词
Trishomocubanes; Sigma receptors; CNS; Structure-activity relationships; ANTIPSYCHOTIC-DRUGS; HIGH-AFFINITY; IN-VITRO; BINDING; RELEASE; DOPAMINE; CLONING; TRISHOMOCUBANES; PROLIFERATION; PHARMACOLOGY;
D O I
10.1016/j.bmcl.2011.04.098
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)] dodecan-3-ols incorporating the respective arylalkyl subunits from several known sigma (sigma) receptor ligands were synthesized and evaluated for their affinity against sigma receptors and dopamine receptors. The hybrid trishomocubane-derived ligands (4-6) showed good selectivity for sigma(1) and sigma(2) receptors over multiple dopamine receptors. The molecular hybrid obtained from haloperidol and 4-azahexacyclo[ 5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)] dodecan-3-ol (4, sigma(1) K-i = 27 nM, sigma(2) K-i = 55 nM) showed reduced affinity for D-1-D-5 dopamine receptors when compared to haloperidol itself. The compound with the greatest sigma(1) affinity in the series, benzamide 4 (sigma(1) K-i = 7.6 nM, sigma(2) K-i = 225 nM) showed a complete reversal of the subtype selectivity displayed by the highly sigma(2) selective parent benzamide, RHM-2 (3, sigma(1) K-i = 10412 nM, sigma(2) K-i = 13.3 nM). (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3622 / 3626
页数:5
相关论文
共 48 条
[11]   Release of [H-3]dopamine from guinea pig striatal slices is modulated by sigma(1) receptor agonists [J].
Gonzalez, GM ;
Werling, LL .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (04) :455-461
[12]   SIGMA-RECEPTOR REGULATION OF NOREPINEPHRINE RELEASE FROM RAT HIPPOCAMPAL SLICES [J].
GONZALEZALVEAR, GM ;
WERLING, LL .
BRAIN RESEARCH, 1995, 673 (01) :61-69
[13]   Sigma receptors: biology and therapeutic potential [J].
Guitart, X ;
Codony, X ;
Monroy, X .
PSYCHOPHARMACOLOGY, 2004, 174 (03) :301-319
[14]   THE SIGMA-1 (σ1) RECEPTOR AND ITS ROLE IN THE TREATMENT OF MOOD DISORDERS [J].
Hayashi, T. ;
Stahl, S. M. .
DRUGS OF THE FUTURE, 2009, 34 (02) :137-146
[15]   Sigma-1 receptor chaperones at the ER-Mitochondrion interface regulate Ca2+ signaling and cell survival [J].
Hayashi, Teruo ;
Su, Tsung-Ping .
CELL, 2007, 131 (03) :596-610
[16]   CLORGYLINE DISPLAYS HIGH-AFFINITY FOR SIGMA-BINDING SITES IN C57BL/6 MOUSE-BRAIN [J].
ITZHAK, Y ;
KASSIM, CO .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 176 (01) :107-108
[17]   Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma [J].
Kashiwagi, Hiroyuki ;
McDunn, Jonathan E. ;
Simon, Peter O., Jr. ;
Goedegebuure, Peter S. ;
Vangveravong, Suwanna ;
Chang, Katherine ;
Hotchkiss, Richard S. ;
Mach, Robert H. ;
Hawkins, William G. .
JOURNAL OF TRANSLATIONAL MEDICINE, 2009, 7
[18]   Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1) [J].
Kekuda, R ;
Prasad, PD ;
Fei, YJ ;
Leibach, FH ;
Ganapathy, V .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 229 (02) :553-558
[19]  
Kobayashi T, 1996, J PHARMACOL EXP THER, V279, P106
[20]   σ-1 receptors in major depression and anxiety [J].
Kulkarni, Shrinivas K. ;
Dhir, Ashish .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (07) :1021-1034